Andriga-10 TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: prednisolone, abiraterone
Brand name
(ARTG)
: ANDRIGA-10 abiraterone 500 mg film-coated tablet and prednisolone 5 mg tablet composite blister packWhat this medicine is used for
(ARTG)
ANDRIGA-5 is indicated for the treatment of:,newly diagnosed high-risk metastatic hormone sensitive prostate cancer (mHSPC) in combinationwith androgen deprivation therapy (ADT).,ANDRIGA-10 is indicated for the treatment of:,patients with metastatic advanced prostate cancer (castration resistant prostate cancer, mCRPC)who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy (ADT)or patients with mCRPC who have received prior chemotherapy containing a taxane.
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Tablet, film coated
- Oral
- Violet, oval, biconvex, film-coated tablets, debossed with '500' on one side
Component :
- Tablet
- Oral
- White, round, biplane uncoated tablets, with a score line on one side
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Shelf lifetime is 18 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 112 abiraterone acetate 500 mg film-coated tablets and 112 prednisolone 5 mg tablets pack
- 56 abiraterone acetate 500 mg film-coated tablets and 56 prednisolone 5 mg tablets pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient abiraterone
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
